Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
The current Merck(MRK) stock price is $104.99, with a market capitalization of 259.93B. The stock trades at a price-to-earnings (P/E) ratio of 13.85 and offers a dividend yield of 3.1%.
During the trading session on 2025-12-23, Merck(MRK) shares reached a daily high of $105.00 and a low of $104.80. At a current price of $104.99, the stock is +0.2% higher than the low and still -0.0% under the high.
Trading volume for Merck(MRK) stock has reached 16.26K, versus its average volume of 18.1M.
Over the past 52 weeks, Merck(MRK) stock has traded between a high of $105.84 and a low of $73.31.
Over the past 52 weeks, Merck(MRK) stock has traded between a high of $105.84 and a low of $73.31.
MRK News
President Donald Trump and nine major pharmaceutical companies announced agreements to lower the cost of medications for cash payers and the government’s Medica...
The Food and Drug Administration awarded national priority vouchers under the Commissioner’s National Priority Voucher pilot program to two investigational prod...
This year has been one to forget for these pharmaceutical giants. Pfizer (PFE +0.54%) and Merck (MRK +0.17%) are two pharmaceutical giants that have lagged bro...
Analyst ratings
57%
of 28 ratingsMore MRK News
Merck & Co. Inc. (NYSE:MRK) will not exercise its option for Evaxion A/S (NASDAQ:EVAX) Gonorrhea vaccine candidate EVX-B2. Gonorrhoea is a common, sexually tra...
The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE:MRK) drugs with potential blockbuster...
Here Are Thursday’s Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck & Co., Rivian, United Airlines, and More Quick...
BMO Capital upgraded Merck (MRK) to Outperform from Market Perform with a price target of $130, up from $82. The firm says the company is assembling a portfolio...
Merck & Co. Inc. (NYSE:MRK) on Wednesday shared topline results from the Phase 3 KEYNOTE-B15 trial (also known as EV-304) in patients with muscle-invasive bladd...
...
Pfizer Inc (NYSE:PFE) and Merck & Co Inc (NYSE:MRK) aren't exciting stocks anymore — and after a bruising reset, that's starting to look intentional. Pfizer's s...